EXTO, BNVI, SAPX, SVMI – Today’s Stock Watchlist

Exit Only, Inc. EXTO

After waiting for quite some time for EXTO to undergo a name change, at last it has finally come to pass. Exit Only will now be officially known as  Bayport International Holdings, Inc., with the new trading symbol yet to be revealed.

The name change filing can be viewed here, on the Nevada Sec. of State website.

EXTO has been good to us since we first began following it this past July, racking up collective gains of nearly 1000%. It has been a flippers dream, making playable swings on nearly a weekly basis.

BioNovo, Inc. BNVI

BNVI is a bottom bounce play for us this morning, and lately our bottom calls have been impeccable! One of our recent bottom-feeding scans yielded BNVI, the newest ground-floor opportunity to hit our radar, has been on a steady downtrend since September.

Yesterday, the stock touched its 52-wk low in the mid-teens, only to close slightly green, finishing the day at .159, for an intraday gain of 15% This was a first glimpse that a possible recovery could be in the making, so we’ll want to keep this one on our tickers for the time being. We would like to see support hold in the teens, as we prepare to catch the very first move from this bottom.

SaVi Media Group, Inc. SVMI

SMVI’s CEO was featured on Stock Traders Talk radio show, and he had some really exciting things to talk about. We really like the idea behind their revolutionary product, a specialized electronic valve which reduces carbon emissions and fuel consumption in your car, while also reducing wear on your engine. Sounds like a win/win to us!

Seven Arts Entertainment, Inc. SAPX

Our first alert for SAPX came on January 12th. The day after our alert, the stock was trading as low as .271, making yesterdays high of .417 a possible gain of 54%

We were waiting to see a breakout on high volume and sure enough, yesterday we had one. Now that momentum is flowing, SAPX could be in for a wild ride in the weeks ahead.

SAPX ran as high as .675 on Halloween, and .63 on Nov 21st. Should the current momentum continue to build, we could see the stock test recent highs, which could mark an additional 75-100% in gains from here.

NSRS, ICPA, BPAX, SAPX – Today’s Stock Watchlist

BioSante Pharmaceuticals, Inc. BPAX

BPAX pushed to a new high on Wednesday, breaking resistance, and hit .75, before closing at .6719. We are going to monitoring closely as the company approaches its FDA date next month.  A positive FDA decision on BPAX’s Bio-T-Gel could be a serious catalyst for more growth in the stock.

Seven Arts Entertainment, Inc. SAPX

Last week, we added SAPX to our radar, and since then it has been trading sideways in a tight channel, seeing little movement in either direction. We want to keep this stock on our radar, waiting to see a pickup in volume which would likely result in a nice PPS increase.

North Springs Resources Corp. NSRS

NSRS exploded yesterday, closing at .825. From our original alert at .253 on Dec.28th, that’s a 232% gain! The stock has been rising steadily over that time, with an extra boost provided by Tuesday’s PR outlining a new LOI:

LAS VEGAS, NEVADA, Jan 17, 2012 (MARKETWIRE via COMTEX) — North Springs Resources Corp. (OTCBB: NSRS)(PINKSHEETS: NSRS) (the “Company” or “North Springs”) is pleased to provide this further update regarding the recently announced Letter of Intent (“LOI”) with Discovery Gold Ghana Limited (“Discovery Gold”) to acquire a ten percent (10%) interest in the Edum Banso Gold Project (“Edum Banso”), a high-potential gold exploration property in Ghana, Africa.

IC Places, Inc. ICPA

This blast from the past did very well for us midway through 2011, and has had a couple of nice bounces as its come down to touch bottom. .0009 and .0011 are our levels of support that we should watch closely; if those levels are lost, things could get ugly fast, but in the meantime, we are treating ICPA as a bottom play with bounce potential. Key resistance points are .003 and .0042.

ICPA was a spotlight on StockTradersTalk radio last night. For those of you that have not checked out the STT, feel encouraged to do so, as the show provides some really good insights into the world of trading for both beginning and experience traders alike. Check it out at StockTradersTalk.com

VSST, BPAX, ATRN, TRID – Today’s Watchlist

BioSante Pharmaceuticals, Inc. BPAX

You’ve heard us say, “if it ain’t broke, don’t fix it”. BPAX broke its resistance on Tuesday, hitting a HOD of .6749, closing the day at .66, and kicking off this short week in good fashion. So far, our total gains on BPAX are sitting at 74%

There are certain groups who believe wrongdoing was taking place with regard to the statements released by the company about its failed product, LibiGel. We are reserving judgement until more information comes to light, but thought you should be made aware of the situation as well. 

NEW YORK, Jan 11, 2012 (BUSINESS WIRE) — Levi & Korsinsky is investigating potential claims on behalf of purchasers of BioSante Pharmaceuticals, Inc. (“BioSante” or the “Company”) (Nasdaq: BPAX) securities concerning possible violations of federal securities laws.

For more information, click here: http://zlk.9nl.com/biosante-pharmaceuticals-bpax.

Atrinsic, Inc. ATRN

ATRN saw a modest 5% increase yesterday, on lighter-than-average volume. It is good to see a consolidation and sideways trading action on decreased volume; it appears as if ATRN is building a new base for its next leg up.

The RSI still appears oversold, and has plenty of room to climb higher from here

Trident Microsystems, Inc. TRID

TRID had its first down day Tuesday since we’ve been following this stock. After 125% in gains, a little pullback is to be expected, but we wont let the symbol slip from our radar just yet. The stock maintained a higher low of .127, only to close at .143, for a 13% intraday gain.

Voice Assist, Inc. VSST

This stock hit its 52-week low yesterday, so we are going to be watching closely for signs that its hit its bottom, that we might catch it on the rebound.

Just as recently as October, VSST was trading in the .70-.80 range, and between 1.25-1.50 back in August. Should the stock recover from this selloff and return to those previous prices, gains of 250%-600% could be in store.

This all may not happen overnight, thus we would categorize this as a long term play. As you’ve seen with our other bottom plays, its always best to begin paying attention early, so as not to miss a beat when the stock begins to turn up from its bottom.  

We think that this company has a great technology that could eventually take off, but don’t take our word for it: The company offers free 30-day trials here.